Da Silva, L C <br/><br/>
Efficacy and tolerability of long-term therapy using high lamivudine doses for the treatment of chronic hepatitis B.  [electronic resource] 

 -  Journal of gastroenterology  Jul 2001 
 - 476-85 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0944-1174 
<br/><br/><label>Standard No.: </label>10.1007/s005350170071  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Alanine Transaminase--blood<br/>Antiviral Agents--administration & dosage<br/>Child<br/>DNA, Viral--genetics<br/>Drug Administration Schedule<br/>Drug Resistance, Viral--genetics<br/>Female<br/>Hepatitis B e Antigens--blood<br/>Hepatitis B virus--drug effects<br/>Hepatitis B, Chronic--drug therapy<br/>Humans<br/>Interferon-alpha--therapeutic use<br/>Lamivudine--administration & dosage<br/>Male<br/>Middle Aged<br/>Mutation<br/>Reverse Transcriptase Inhibitors--administration & dosage<br/>Time Factors<br/>Treatment Outcome<br/>Viremia--drug therapy